Cargando…
Hematological Questions in Personalized Management of COVID-19 Vaccination
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been causing a worldwide pandemic since 2019. Many vaccines have been manufactured and have shown promising results in reducing disease morbidity and mortality. However, a variety of vacc...
Autores principales: | Wu, Tingting, Li, Junying, Hu, Yu, Tang, Liang V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965747/ https://www.ncbi.nlm.nih.gov/pubmed/36836493 http://dx.doi.org/10.3390/jpm13020259 |
Ejemplares similares
-
Hematological features of persons with COVID-19
por: Li, Qiubai, et al.
Publicado: (2020) -
COVID-19 Vaccines and Autoimmune Hematologic Disorders
por: Mingot-Castellano, María Eva, et al.
Publicado: (2022) -
COVID-19 Vaccine: Critical Questions with Complicated Answers
por: Haidere, Mohammad Faisal, et al.
Publicado: (2021) -
Unanswered Questions in HIV Hematology
por: Leitch, Heather A., et al.
Publicado: (2012) -
COVID-19 vaccines: Frequently asked questions and updated answers
por: Lefebvre, M., et al.
Publicado: (2021)